| Basics |
Ekso Bionics Holdings, Inc. Common Stock
Ekso Bionics Holdings Inc designs, develops and sells wearable bionic human exoskeletons that have applications in healthcare, industrial, military, and consumer markets.
|
| IPO Date: |
January 16, 2014 |
| Sector: |
Healthcare |
| Industry: |
Medical Instruments & Equipment |
| Market Cap: |
$11.05M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.10 | 3.93%
|
| Avg Daily Range (30 D): |
$0.05 | 6.16%
|
| Avg Daily Range (90 D): |
$0.03 | 4.83%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.34M |
| Avg Daily Volume (30 D): |
3.11M |
| Avg Daily Volume (90 D): |
1.18M |
| Trade Size |
| Avg Trade Size (Sh.): |
311 |
| Avg Trade Size (Sh.) (30 D): |
417 |
| Avg Trade Size (Sh.) (90 D): |
422 |
| Institutional Trades |
| Total Inst.Trades: |
11 |
| Avg Inst. Trade: |
$.89M |
| Avg Inst. Trade (30 D): |
$M |
| Avg Inst. Trade (90 D): |
$M |
| Avg Inst. Trade Volume: |
.12M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$.79M |
| Avg Closing Trade (30 D): |
$M |
| Avg Closing Trade (90 D): |
$M |
| Avg Closing Volume: |
158.35K |
|
|
| Financials |
| |
TTM |
Q2 2024 |
Q1 2024 |
|
Basic EPS
|
$-.12
|
$-.13
|
$-.2
|
|
Diluted EPS
|
$-.12
|
$-.13
|
$-.2
|
|
Revenue
|
$ 3.38M
|
$ 4.95M
|
$ 3.76M
|
|
Gross Profit
|
$ 1.81M
|
$ 2.64M
|
$ 1.95M
|
|
Net Income / Loss
|
$ -2.89M
|
$ -2.42M
|
$ -3.43M
|
|
Operating Income / Loss
|
$ -3.44M
|
$ -2.34M
|
$ -3.26M
|
|
Cost of Revenue
|
$ 1.57M
|
$ 2.31M
|
$ 1.81M
|
|
Net Cash Flow
|
$ 1.56M
|
$ -2.91M
|
$ .16M
|
|
PE Ratio
|
|
|
|
| Splits |
|
Mar 25, 2020:
1:15
|
|
May 05, 2016:
1:7
|
|
|
|
